Berkshire Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Berkshire Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$201K	Sell	401 -18	-4%	-$8.64K	0.01%	267
2026 Q1	$206K	Sell	419 -245	-37%	-$133K	0.01%	254
2025 Q4	$385K	Buy	664 +233	+54%	+$132K	0.02%	198
2025 Q3	$209K	Buy	+431	New	+$201K	0.01%	284
2025 Q1	–	Sell	-369	Closed	-$212K	–	296
2024 Q4	$212K	Hold	369	–	–	0.01%	267
2024 Q3	$204K	Hold	369	–	–	0.01%	273
2024 Q2	$204K	Hold	369	–	–	0.01%	275
2024 Q1	$214K	Buy	+369	New	+$207K	0.01%	230

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Berkshire Asset Management's TMO Position: Q2 2026 in Review

Berkshire Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 4.3% in Q2 2026, selling an estimated $8.64K and leaving 401 shares worth $201K. The position accounts for 0.01% of the portfolio, ranked #267.

Berkshire Asset Management first reported a position in TMO in Q1 2024 and has held it in 8 quarters since. The position peaked at $385K in Q4 2025. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Berkshire Asset Management held 401 shares of Thermo Fisher Scientific worth $201K as of Q2 2026.
Berkshire Asset Management sold 18 Thermo Fisher Scientific shares in Q2 2026, an estimated $8.64K.
Thermo Fisher Scientific made up 0.01% of Berkshire Asset Management's portfolio in Q2 2026, its #267 holding.
Berkshire Asset Management first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 8 quarters since.
Berkshire Asset Management's Thermo Fisher Scientific position peaked at $385K in Q4 2025.
1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Berkshire Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.